CiteAb 2023: Highly Commended in the Innovation Award Category
27 March 2023
Krishgen is proud to be Highly Commended in the Innovation Award category at the 2023 CiteAb awards. The CiteAb Innovation Award highlights an innovative product that has satisfied a gap in the market or solved a known issue within the respective field. Krishgen’s unique and highly specific immunoassays for the detection of bispecific antibodies are the first such commercialized ELISA in the world.
The award was given to us at the AACR meeting 2023 in Orlando by the CiteAb team!
Learn more about the annual CiteAb awards: https://www.citeab.com/awards
View our 40+ targets for Bispecific Antibody Drug ELISA, designed for quantification of drug in serum and plasma samples for pharmacokinetic analysis here
These assays are developed using anti-idiotypic antibodies that allow for specificity and accuracy. Our validation protocols ensure robustness and sensitivity.
We are pleased to be recognized with this accolade and endeavour to create more products that are unique to the market and fulfil the needs of scientists and researchers working on cutting-edge technologies and therapies.
View our Product Guides:
